Diabetic macular edema in proliferative stage treated with anti-vascular endothelial growth factor agent and triamcinolone acetonide by laser-based strategies | Zendy

Gang Qiao | Zendy; Wan-Jiang Dong | Zendy; Yan Dai | Zendy; Zhenhua Jiang | Zendy; Haike Guo | Zendy

Open Access

Diabetic macular edema in proliferative stage treated with anti-vascular endothelial growth factor agent and triamcinolone acetonide by laser-based strategies

Author(s) -

Gang Qiao,

Wan-Jiang Dong,

Yan Dai,

Zhenhua Jiang,

Haike Guo

Publication year - 2017

Publication title -

international journal of ophthalmology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.634

H-Index - 29

eISSN - 2227-4898

pISSN - 2222-3959

DOI - 10.18240/ijo.2017.07.15

Subject(s) - medicine , triamcinolone acetonide , diabetic macular edema , ophthalmology , visual acuity , diabetic retinopathy , acetonide , macular edema , randomized controlled trial , panretinal photocoagulation , vascular endothelial growth factor , surgery , vegf receptors , diabetes mellitus , endocrinology

To appraise the effect of treatment for diabetic macular edema (DME) in proliferative stage with sufficient panrentinal photocoagulation (PRP) therapy and intravitreal injections (IV) Conbercept and posterior subtenon's triamcinolone acetonide (STTA) sequential therapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research